Opus Genetics

Opus Genetics Tangible Book Value per Share

The Tangible Book Value per Share of Opus Genetics (IRD) as of Oct 17, 2026 is 0.22 USD. In the previous year, Tangible Book Value per Share was 0.10 USD — a change of 128.26% (higher).

Tangible Book Value per Share

0.22USD

YoY

128.26%

Last updated:

Tangible Book Value per Share of Opus Genetics is 2025 0.22 USD. Tangible Book Value per Share of Opus Genetics was 2024 0.10 USD. It decreases by 128.26% higher compared to the previous year.

The Opus Genetics Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2018
0.15 USD
Jan 1, 2019
-0.11 USD
Jan 1, 2020
-0.20 USD
Jan 1, 2021
0.32 USD
Jan 1, 2022
0.67 USD
Jan 1, 2023
0.72 USD
Jan 1, 2024
0.10 USD
Jan 1, 2025
0.22 USD
The Opus Genetics Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
0.22USD+128.26%
0.10USD-86.53%
0.72USD+7.93%
0.67USD+108.08%
0.32USD-265.01%
-0.20USD+78.13%
-0.11USD-171.59%
0.15USD-37.03%
0.24USD-1.70%
0.25USD-9.16%
0.27USD-29.35%
0.39USD-99.05%
40.74USD+6.88%
38.12USD-28.81%
53.55USD-7.32%
57.78USD+76.87%
32.67USD+61.98%
20.17USD-62.48%
53.75USD+85.34%
29.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Opus Genetics Stock analysis

What does Opus Genetics do? Ocuphire Pharma, Inc. is a health care company based in Farmington Hills, Michigan, specializing in the research and development of ophthalmic biopharmaceuticals. Listed on the market on 30 November 2004, the firm focuses on therapies for refractive and retinal eye disorders. Its pipeline features Nyxol Eye Drops, a once-daily formulation of phentolamine mesylate aimed at reducing pupil diameter and improving visual acuity for conditions such as presbyopia and night vision disturbances. Additionally, the company develops APX3330, an oral tablet targeting retinal and choroidal diseases, alongside in-licensed second-generation candidates APX2009 and APX2014. The organization employs a small team dedicated to advancing these innovative treatments. Opus Genetics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Opus Genetics stock

Tangible Book Value per Share of Opus Genetics is 0.22 USD in 2025.

Tangible Book Value per Share of Opus Genetics changed from 0.10 USD to 0.22 USD, representing a 128.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share Opus Genetics since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Opus Genetics

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Opus Genetics